How to Appeal a Migraine Prior Authorization Denial

Knowing how to appeal a migraine prior authorization denial is one of the more practically useful things a migraine patient can learn. Denials feel final, but they are not. Every insurer operating under standard commercial insurance rules is required to provide an appeals process, and a meaningful share of CGRP prior authorization denials are reversed on appeal when the appeal includes thorough clinical documentation. The process has multiple stages, each with a different approach, and understanding what each stage looks like gives you and your prescriber the best shot at overturning a denial.

Why Prior Authorization Denials Happen

Before appealing, it helps to know exactly why the denial occurred. The denial letter your insurer sends is required to include the specific reason. Read it carefully before your prescriber's office does anything else. Common reasons include:

• Step therapy not satisfied. The insurer requires documented failure of one or more older preventive medications before approving a CGRP inhibitor. If the documentation on file does not clearly show what was tried, at what dose, for how long, and why it failed, this is often the denial reason.
• Insufficient documentation of medical necessity. The clinical notes submitted did not establish migraine frequency, disease burden, or diagnosis clearly enough to meet the plan's criteria.
• Criteria for chronic vs. episodic migraine not met. Some plans apply different coverage criteria depending on diagnosis. If submitted documentation describes episodic migraine but the plan's threshold requires chronic migraine (15 or more headache days per month), the frequency data has to be there in the records. See episodic vs. chronic migraine for more on how these categories are defined.
• Missing baseline migraine day data. Without a documented pre-treatment migraine frequency, there is no way to demonstrate either disease severity or treatment response. This is one of the most common documentation gaps.
• Formulary or non-covered medication issue. The specific medication requested may not be on the plan's formulary, or a different agent may be preferred. This may require a formulary exception rather than a standard clinical appeal.

Identifying the exact reason shapes what you put in the appeal. An appeal that addresses the wrong issue will not succeed.

How to Appeal Migraine Prior Authorization Denial: The First-Level Appeal

The first-level internal appeal is a written submission to the insurer asking them to reconsider the denial. Your prescriber's office typically prepares and submits this, but you can and should be actively involved in ensuring the documentation is complete.

What a strong first-level appeal includes:

• A clinical letter from your prescribing physician. This is not a form. It should be a narrative letter explaining your diagnosis, your migraine history, your documented monthly migraine day frequency (with specific numbers, not general descriptions), and why the requested medication is medically necessary for you specifically.
• Corrected or expanded step therapy documentation. If the denial was based on insufficient step therapy records, the appeal needs to provide full documentation of each prior preventive tried: the medication name, dose, duration of trial, and the specific reason for failure, whether inadequate efficacy or adverse effects.
• Quantified migraine day data. This is where patient-kept tracking records have direct clinical value. A log showing documented migraine days per month, along with acute medication usage and severity, gives the prescriber concrete numbers to cite in the appeal letter rather than estimates. If you have a CGRP renewal report, that data belongs in the appeal packet.
• Relevant clinical guidelines. Your prescriber may include references to major neurology society guidelines supporting CGRP use for your diagnosis profile.
• Functional or disability data. Validated scores like MIDAS or HIT-6 quantify how migraine affects your daily function and add weight to a medical necessity argument.

File the appeal within the deadline stated in your denial letter. Keep copies of everything submitted and document the submission date.

Peer-to-Peer Review: Often the Fastest Path

Many first-level appeal denials, and sometimes denials that have not yet gone through a formal written appeal, can be addressed through a peer-to-peer review. This is a direct physician-to-physician phone call between your neurologist or prescribing clinician and the insurer's medical reviewer.

Peer-to-peer calls have a high reversal rate for CGRP denials because the conversation happens in real time, and your clinician can address the medical reviewer's specific questions directly. The reviewer has often seen only a brief clinical summary, not the full picture of your history.

Your prescriber's office has to request the peer-to-peer. Ask them explicitly whether they will do this if the written appeal alone is rejected, or in some cases, whether they want to attempt it before or alongside the formal written appeal. Not every office proactively pursues this step, and the patient asking for it specifically makes a difference.

Step Therapy Exception Requests

If your denial is rooted in step therapy requirements, and you have already tried some or all of the required medications previously (perhaps through a prior insurer, or years before this plan's requirements were in place), you may be eligible for a step therapy exception rather than having to re-trial those medications.

Many states have enacted step therapy exception laws that set timelines and criteria under which insurers must grant exceptions. Common qualifying grounds include:

• The required medication is contraindicated for you
• You previously tried and failed the required medication
• Re-trialing the medication would cause harm or significant delay in care
• You are currently stable on the prescribed treatment and switching would cause disruption

Your prescriber can submit a formal exception request with documentation of prior treatment failure. Your state's insurance department website is the most reliable source for information about what protections apply in your state, since these rules vary significantly by jurisdiction. The guide on step therapy for migraine covers how these policies typically work in practice.

Second-Level Internal Appeal and External Review

If the first-level internal appeal is denied, most plans offer a second-level internal appeal, typically reviewed by a different or more senior medical reviewer. The same documentation principles apply, but your prescriber may add additional clinical detail or a stronger narrative addressing the specific reason for the second denial.

After exhausting internal appeals, you generally have the right to request an independent external review. This review is conducted by a third-party organization that operates independently of the insurer. The external reviewer's decision is typically binding on the insurer. External review is worth pursuing when the clinical case is strong and internal processes have been exhausted.

You may also file a complaint with your state's insurance commissioner if you believe the denial or appeals process is not being handled in accordance with state law. This is separate from the clinical appeal process but can sometimes accelerate resolution.

What Strengthens Every Stage of the Appeal

Across every level of the appeals process, the common thread is specificity. Vague documentation loses. Specific, quantified, dated documentation wins.

For more on the underlying documentation that goes into coverage cases for CGRP medications, the CGRP prior authorization renewal guide covers what insurers typically need to see at each stage, including what a strong renewal packet contains.

What to Do While the Appeal Is Pending

Ask your prescriber's office whether the insurer is required to provide an expedited appeals timeline given your medical situation. For non-urgent cases, standard timelines apply, but if continuing or starting this treatment is time-sensitive, expedited review may be available. Ask about it explicitly.

Some manufacturers of CGRP medications offer patient assistance programs or bridge supply programs for patients in the middle of an insurance dispute. Eligibility and availability vary, and programs change, so contact the manufacturer's patient support line or ask your pharmacist whether options exist. The CGRP treatment cost resource covers financial assistance options in more detail if you need coverage alternatives while an appeal is pending.

How Tracking Data Changes the Appeal Outcome

The appeal process runs on documentation. Every stage requires your prescriber to make a clinical argument with specific evidence, and the most specific evidence you can contribute is a detailed, consistently maintained migraine log. Monthly migraine day counts, acute medication use, headache severity, and duration recorded in real time produce a very different kind of appeal packet than one reconstructed from memory or estimated from sparse clinic notes.

Patients who track consistently throughout their treatment give their prescribers the raw material for a strong, credible appeal at any stage. Whether you are appealing an initial denial or pushing back on a renewal refusal, a record showing exactly how many migraine days you had before treatment, and exactly how that number changed after, is the most straightforward evidence that the medication is necessary and working. A tool like the migraine reduction calculator can help quantify the change in migraine frequency in the format most legible in a prior authorization context. The same data that supports your monthly migraine day tracking supports your coverage case, and building that habit from the start of treatment means you are never reconstructing twelve months of headache history when an appeal deadline is forty-five days out.